VIR logo

VIR
Vir Biotechnology Inc

6,837
Mkt Cap
$1.67B
Volume
752,180.00
52W High
$10.94
52W Low
$4.16
PE Ratio
-3.31
VIR Fundamentals
Price
$10.35
Prev Close
$10.46
Open
$10.50
50D MA
$8.81
Beta
1.63
Avg. Volume
3.16M
EPS (Annual)
-$3.16
P/B
1.91
Rev/Employee
$186,801.09
$464.19
Loading...
Loading...
News
all
press releases
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that its global collaboration and licensing agreement with Astellas announced on February 23, 2026 has closed following expiration of the waiting...
Business Wire·8h ago
News Placeholder
More News
News Placeholder
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first patient has been dosed in one of three expansion cohorts in the Phase 1 trial evaluating VIR-5500, a prostate-specific membrane...
Business Wire·3d ago
News Placeholder
Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000
Key Points72,559 shares were sold for a total transaction value of ~$664,000 on April 6, 2026...
Nasdaq News: Markets·4d ago
News Placeholder
Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR
Aberdeen Group plc trimmed its holdings in shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) by 8.9% during the fourth quarter, according to its most recent 13F filing with the Securities...
MarketBeat·8d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) CEO Sells $664,640.44 in Stock
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) CEO Backer Marianne De sold 72,559 shares of the business's stock in a transaction that occurred on Monday, April 6th. The stock was sold at an average price of $9.16, for a total value of $664,640.44. Following the completion of the...
MarketBeat·8d ago
News Placeholder
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) have received an average recommendation of "Moderate Buy" from the ten analysts that are presently covering the stock, MarketBeat.com...
MarketBeat·8d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) CEO Backer Marianne De sold 72,559 shares of the stock in a transaction dated Monday, April 6th. The stock was sold at an average price of...
MarketBeat·9d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Director Sells $199,540.00 in Stock
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) Director Vicki Sato sold 22,000 shares of the business's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $9.07, for a total value of $199,540.00. Following the completion of the...
MarketBeat·14d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) CAO Brent Sabatini Sells 7,711 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) CAO Brent Sabatini sold 7,711 shares of the business's stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an...
MarketBeat·21d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) CAO Sells $70,324.32 in Stock
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) CAO Brent Sabatini sold 7,711 shares of Vir Biotechnology stock in a transaction dated Monday, March 23rd. The shares were sold at an average...
MarketBeat·22d ago
<
1
2
...
>

Latest VIR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.